Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery

12Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Enoyl-acyl carrier protein reductase (ENR) is a crucial enzyme in the type II fatty acid synthesis pathway of many pathogens such as Plasmodium falciparum, the etiological agent of the most severe form of malaria. Because of its essential function of fatty acid double bond reduction and the absence of a human homologue, PfENR is an interesting drug target. Although extensive knowledge of the protein structure has been gathered over the last decade, comparatively little remains known about the dynamics of this crucial enzyme. Here, we perform extensive molecular dynamics simulations of tetrameric PfENR in different states of cofactor and ligand binding, and with a variety of different ligands bound. A pocket-volume analysis is also performed, and virtual screening is used to identify potential druggable hotspots. The implications of the results for future drug-discovery projects are discussed. © 2012 The Protein Society.

Cite

CITATION STYLE

APA

Lindert, S., & McCammon, J. A. (2012). Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery. Protein Science, 21(11), 1734–1745. https://doi.org/10.1002/pro.2155

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free